Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Due to the availability of effective combination chemotherapies such as gemcitabine/nab-paclitaxel (GNP) or FOLFIRINOX, neoadjuvant treatment of borderline resectable (BRPC) and locally advanced pancreatic cancer (LAPC) has been increasingly investigated in recent years. However, due...

Descripción completa

Detalles Bibliográficos
Autores principales: Damm, Marko, Efremov, Ljupcho, Birnbach, Benedikt, Terrero, Gretel, Kleeff, Jörg, Mikolajczyk, Rafael, Rosendahl, Jonas, Michl, Patrick, Krug, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430874/
https://www.ncbi.nlm.nih.gov/pubmed/34503138
http://dx.doi.org/10.3390/cancers13174326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430874/
https://www.ncbi.nlm.nih.gov/pubmed/34503138
http://dx.doi.org/10.3390/cancers13174326

Ejemplares similares